These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 31059665

  • 1. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
    Tom MC, Nguyen JK, Lucianò R, Mian OY, Stephans KL, Ciezki JP, Smile TD, Wei W, McKenney JK, Magi-Galluzzi C, Tendulkar RD.
    J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
    Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ.
    Mod Pathol; 2017 Aug; 30(8):1126-1132. PubMed ID: 28530220
    [Abstract] [Full Text] [Related]

  • 5. Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy.
    Van der Kwast T, Al Daoud N, Collette L, Sykes J, Thoms J, Milosevic M, Bristow RG, Van Tienhoven G, Warde P, Mirimanoff RO, Bolla M.
    Eur J Cancer; 2012 Jun; 48(9):1318-25. PubMed ID: 22405699
    [Abstract] [Full Text] [Related]

  • 6. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
    Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, Incrocci L, Bangma CH, van der Kwast TH, Roobol MJ, van Leenders GJ.
    Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
    Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA.
    Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
    [Abstract] [Full Text] [Related]

  • 10. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S, Gertner M, Maganti M, Pintilie M, Perlis N, Toi A, Evans AJ, Finelli A, van der Kwast TH, Ghai S.
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [Abstract] [Full Text] [Related]

  • 11. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.
    Kweldam CF, Wildhagen MF, Steyerberg EW, Bangma CH, van der Kwast TH, van Leenders GJ.
    Mod Pathol; 2015 Mar; 28(3):457-64. PubMed ID: 25189638
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis.
    Spratt DE, Zumsteg Z, Ghadjar P, Pangasa M, Pei X, Fine SW, Yamada Y, Kollmeier M, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1254-61. PubMed ID: 23182392
    [Abstract] [Full Text] [Related]

  • 14. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.
    Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, van der Kwast TH, Roobol MJ, van Leenders GJ.
    Mod Pathol; 2016 Jun 01; 29(6):630-6. PubMed ID: 26939875
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
    Yu HH, Song DY, Tsai YY, Thompson T, Frassica DA, DeWeese TL.
    Urology; 2007 Jul 01; 70(1):111-6. PubMed ID: 17656219
    [Abstract] [Full Text] [Related]

  • 20. Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy.
    Vance SM, Stenmark MH, Blas K, Halverson S, Hamstra DA, Feng FY.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):940-6. PubMed ID: 22056069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.